Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1903-1909

  Prinz, Christian ^a   Schöniger, Martin ^a   Rad, Roland ^a   Becker, Ingrid ^a   Keiditsch, Erwin ^a   Wagenpfeil, Stephan ^a   Classen, Meinhard ^a   Rösch, Thomas ^a   Schepp, Wolfgang ^a   Gerhard, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BLOOD GROUP ANTIGEN; VIRULENCE FACTOR;

ANTIGEN BINDING; ARTICLE; BACTERIUM ADHERENCE; BLOOD GROUP LEWIS SYSTEM; CHRONIC GASTRITIS; FEMALE; GENE TARGETING; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; STOMACH BIOPSY;

ADHESINS, BACTERIAL; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; BIOPSY; CARRIER PROTEINS; CHRONIC DISEASE; FEMALE; GASTRITIS; GASTRITIS, ATROPHIC; GENOTYPE; GRANULOCYTES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; LEWIS BLOOD-GROUP SYSTEM; LYMPHOCYTES; MALE; METAPLASIA; MIDDLE AGED; STOMACH;

EID: 0035266309     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Helicobacter pylori in peptic ulcer disease. NIH Consensus Conference
2. Helicobacter pylori infection and the risk of gastric carcinoma
3. Helicobacter prlori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils
4. Long-term sequelae of experimental gastritis with Helicobacter pylori: A 5-year follow-up study
5. Development of Helicobacter prlori-induced gastric carcinoma in Mongolian gerbils
6. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
7. Gastric mucosal inflammatory responses to Helicobacter pylori
8. Immune and inflammatory responses to Helicobacter pylori infection
9. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety
10. Long-term sequelae of Helicobacter pylori gastritis
11. Phenotypic and genotypic events in gastric carcinogenesis
12. Determinants of Helicobacter pylori infection and chronic gastritis
13. Differing degree and distribution of gastritis in Helicobacter pylori-associated diseases
14. Helicobacter pylori and the evolution of gastritis
15. Gastric carcinoma risk index in patients infected with Helicobacter pylori
16. Pathogenesis of the transformation from gastritis to malignancy
17. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
18. The vacuolating cytotoxin of Helicobacter pylori
19. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration
20. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
21. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
22. Helicobacter pylori virulence and genetic geography
23. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
24. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion
25. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation
26. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens
27. Helicobacter pylori adhesin binding fucosylated histo-blood group antigen revealed by retagging
28. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin
29. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study
30. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases
31. The Sydney System: Epidemiology and natural history of chronic gastritis
32. Geographic distribution of vacA allelic types of Helicobacter pylori
33. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori
34. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori
35. Gastric adenocarcinoma and Helicobacter pylori infection
36. Helicobacter pylori and gastric cancer
37. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains
38. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis
39. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers
40. Effect of Helicobacter pylori vacuolating toxin on maturation and extra-cellular release of procathepsin D and on epidermal growth factor degradation
41. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA
42. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH
43. Helicobacter pylori: Molecular basis for host recognition and bacterial adherence
44. An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium
45. Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori
46. Severity of Helicobacter pylori gastritis predicts duodenal ulcer recurrence
47. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study
48. Classification principles and genetics of chronic gastritis
49. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study
50. Intestinal metaplasia-its association with gastric cancer
51. Helicobacter pylori infection and gastric neoplasia: Correlations with histological gastritis and tumor histology
52. Lewis, secretor, and ABO phenotypes, and sulfomucin expression in gastric intestinal metaplasia